USA flag logo/image

An Official Website of the United States Government

IMPLANTABLE BLOOD FLOW DEVICE

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
54057
Program Year/Program:
2001 / SBIR
Agency Tracking Number:
1R43HL066891-01
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
DATA SCIENCES INTERNATIONAL, INC
4211 LEXINGTON AVE N ST. PAUL, MN 55126
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2001
Title: IMPLANTABLE BLOOD FLOW DEVICE
Agency: HHS
Contract: N/A
Award Amount: $134,467.00
 

Abstract:

DESCRIPTION (Unedited Applicant's Abstract): This proposed Phase I effort will evaluate the feasibility of developing an implantable device for telemetric monitoring of blood flow in palliative shunts in children as small as neonates with congenital heart disease. In these patients, these surgically placed shunts represent a lifeline through which all pulmonary circulation flows. Further, an imbalance between pulmonary and systemic blood flow in these patients due to stenosis of the shunt, growth of the patient, or inappropriate systemic or pulmonary vascular resistance can be life-threatening. We believe that serial quantitative measurements of volume shunt flow will lead to improved management of these patients and will result in reduced mortality, morbidity, and cost of care. Currently, the only method available to measure quantitative flow in these shunts is angiography, an invasive procedure that is suitable only in limited circumstances. As part of this effort, we will evaluate the feasibility of implementing the proposed device using an innovative flexible and adaptable architecture that has broad application for telemetering not only blood flow, but blood pressure, ECG, temperature, and cardio thoracic other signals. A highly qualified DSI staff and surgeon will team to investigate this new technology and to establish the potential for Phase II and Phase III success. PROPOSED COMMERCIAL APPLICATION: Successful completion will build the foundation for implementation of a valuable new tool for chronic clinical assessment of blood flow in human beings. Such a tool is currently unavailable and without precedence. Moreover, sucess in this effort should lead to development of additional telemetry devices for key human health applications.

Principal Investigator:

Brian P. Brockway

Business Contact:


6514817410
WWW.DATASCI.COM
Small Business Information at Submission:

DATA SCIENCES INTERNATIONAL, INC
4211 LEXINGTON AVE N ST. PAUL, MN 55126

EIN/Tax ID: 411500649
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No